Stephan Rogalla is a physician-scientist with over a decade of experience in gastrointestinal oncology, molecular imaging, and immunology. Currently, they serve as Medical Director and Clinical Lead at Riboscience, overseeing a Phase 1a/b clinical trial of an ENPP1 inhibitor for advanced solid tumors. Additionally, they hold the position of Clinical Assistant Professor at Stanford University, focusing on research in early cancer detection and biomarker discovery. Their previous roles include postdoctoral fellowships in molecular imaging at Stanford and residency training in internal medicine and surgery at Charité. Rogalla is actively engaged in exploring leadership opportunities in biotech and pharmaceutical innovation in oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices